HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

lipoprotein-associated coagulation inhibitor (TFPI)

MW 38,000; produced by HepG2 hepatoma & other cells; requires factor VII(a), factor X(a) & Ca++ to express inhibitory activity
Also Known As:
TFPI; tissue factor pathway inhibitor; EPI I (extrinsic pathway inhibitor I); LACI inhibitor; TFI HepG2; TFPI-beta; TFPIbeta; Xa-dependent factor VIIa-TF inhibitor; anticonvertin; antithromboplastin; extrinsic pathway inhibitor I; tissue factor inhibitor, hepatoma
Networked: 956 relevant articles (48 outcomes, 216 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sandset, Per Morten: 27 articles (01/2021 - 12/2002)
2. Mast, Alan E: 21 articles (01/2022 - 03/2007)
3. Iversen, Nina: 19 articles (01/2021 - 01/2002)
4. Maroney, Susan A: 16 articles (01/2022 - 03/2007)
5. Skretting, Grethe: 16 articles (01/2019 - 06/2010)
6. Stavik, Benedicte: 13 articles (01/2019 - 06/2010)
7. Nadir, Yona: 12 articles (01/2020 - 11/2005)
8. Brenner, Benjamin: 12 articles (04/2016 - 11/2005)
9. Mousa, Shaker A: 11 articles (01/2021 - 02/2002)
10. Simari, Robert D: 10 articles (01/2021 - 04/2003)

Related Diseases

1. Sepsis (Septicemia)
2. Hemophilia A (Haemophilia)
3. Thrombosis (Thrombus)
4. Hemorrhage
5. Hyperplasia

Related Drugs and Biologics

1. Antithrombins
2. lipoprotein-associated coagulation inhibitor (TFPI)
3. Protein C
4. Anticoagulants
5. Heparin (Liquaemin)
6. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
7. Dacarbazine (DIC)
8. concizumab
9. Antibodies
10. Thromboplastin (Tissue Factor)

Related Therapies and Procedures

1. Therapeutics
2. Free Tissue Flaps
3. Continuous Ambulatory Peritoneal Dialysis (CAPD)
4. Peritoneal Dialysis
5. Estrogen Replacement Therapy